Oncolytics Biotech Inc.
ONC.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -58.09% | -50.92% | -1.26% | -0.31% | 11.33% |
| Total Receivables | 314.91% | 89.19% | 977.75% | -2.08% | -53.28% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -46.70% | -55.10% | -46.51% | -20.97% | 95.91% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 90.14% | 96.26% | -0.56% | -- |
| Total Current Assets | -54.62% | -49.39% | -4.38% | -2.65% | 9.63% |
|
|
|||||
| Total Current Assets | -54.62% | -49.39% | -4.38% | -2.65% | 9.63% |
| Net Property, Plant & Equipment | 86.12% | 79.64% | 86.76% | 62.74% | 1.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -52.27% | -47.29% | -2.94% | -1.72% | 6.56% |
|
|
|||||
| Total Accounts Payable | -7.79% | 56.91% | 36.29% | 40.80% | -50.76% |
| Total Accrued Expenses | 36.57% | 48.98% | 109.94% | 68.06% | 82.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 91.16% | 31.59% | 63.75% | -5.37% | -36.90% |
| Total Finance Division Other Current Liabilities | 179.17% | -90.74% | 696.45% | 553.24% | 589.73% |
| Total Other Current Liabilities | 179.17% | -90.74% | 696.45% | 553.24% | 589.73% |
| Total Current Liabilities | 44.86% | -23.42% | 123.98% | 66.05% | 10.07% |
|
|
|||||
| Total Current Liabilities | 44.86% | -23.42% | 123.98% | 66.05% | 10.07% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 149.09% | 152.01% | 149.14% | 150.57% | 89.31% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -8.22% | 0.13% | -3.25% | -0.08% | 2.48% |
| Total Liabilities | 15.81% | -10.81% | 36.85% | 22.91% | 6.50% |
|
|
|||||
| Common Stock & APIC | -6.33% | 1.77% | 1.85% | 5.56% | 9.16% |
| Retained Earnings | 1.69% | -6.39% | -3.03% | -6.55% | -9.28% |
| Treasury Stock & Other | 62.15% | -0.17% | 26.08% | 1.58% | -15.78% |
| Total Common Equity | -80.08% | -68.75% | -20.34% | -10.88% | 6.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -80.08% | -68.75% | -20.34% | -10.88% | 6.59% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -80.08% | -68.75% | -20.34% | -10.88% | 6.59% |
|
|
|||||